COMPLETE RESPONSE in Croatian translation

• kompletan odgovor
• potpuni odgovor
• potpuna reakcija
• potpunog odgovora
• potpun odgovor
• potpunim odgovorom
• kompletnog odgovora
• kompletni odgovor

Examples of using Complete response in English and their translations into Croatian

The median duration of complete response was 42.1 months in the BR-CAP group compared with 18 months in the R- CHOP group.
Medijan trajanja kompletnog odgovora bio je 42, 1 mjesec u BR-CAP skupini u usporedbi s 18 mjeseci u R-CHOP skupini.

Efficacy was based on evaluation of the following composite measures: complete response in both the overall and delayed phases
Ocjena djelotvornosti zasnivala se na temelju sljedećih skupnih mjera ishoda: potpunom odgovoru na liječenje tijekom cijelog razdoblja

or partial or complete response, provided that the product is sufficiently well tolerated.
ili djelomične ili potpune reakcije, pod uvjetom da životinja zadovoljavajuće podnosi proizvod.

43.8% achieved complete response.
43,8% postiglo je potpun odgovor.

attained an 87% objective response rate, including a complete response in 16% of patients.
liječili BRAF inhibitorom(n 63) ostvarili su stopu objektivnog odgovora od 87%, a 16% njih ostvarilo je potpun odgovor.

After 6 weeks of treatment, a complete response was noted for 8.1%
Nakon šest tjedana terapije kompletna reakcija zabilježena je na 8,

The DCR(complete response or partial response
Stopa kontrole bolesti(DCR, bolesnici s potpunim odgovorom, djelomičnim odgovorom

ORR defined as the proportion of subjects who achieved a complete response(CR) or partial response(PR)
ORR je definiran kao udio ispitanika koji su postigli potpuni odgovor(CR, complete response)

Seventy-three percent of nucleoside-experienced and 69% of nucleoside-naïve patients achieved complete response to treatment; 90% of nucleoside-experienced and 88% of nucleoside-naïve
U 73% pacijenata koji su primali nukleozide i 69% pacijenata koji prethodno nisu primali nukleozide postigao se potpuni odgovor na liječenje; u 90% pacijenata koji su primali nukleozide

71% of the HBeAg-negative and 67% of HBeAg-positive patients taking Viread had a complete response to treatment, compared with 49%
67% HBeAg pozitivnih bolesnika koji su uzimali Viread imalo je kompletan odgovor na liječenje u usporedbi s 49%,

The primary efficacy endpoint was Complete Response in the acute phase of the first cycle of chemotherapy,
Primarni ishod djelotvornosti bio je potpuni odgovor u akutnoj fazi prvog ciklusa kemoterapije,

had a complete response to treatment after a month,
je imalo kompletan odgovor na terapiju nakon mjesec dana,

55% of the patients(298 out of 541) taking Emend capsules at a dose of 40 mg had a complete response, compared with 49% of the patients who received ondansetron 258 out of 526.
u 55% bolesnika(298 od 541) koji su uzimali kapsule lijeka Emend u dozi od 40 mg zabilježena je potpuna reakcija, u usporedbi s 49% bolesnika koji su primali ondansetron 258 od 526.

The primary efficacy endpoint was overall response rate defined as the percentage of patients who achieved an objective confirmed complete response or partial response based on an independent,
Primarni ishod djelotvornosti bila je ukupna stopa odgovora definirana kao postotak bolesnika koji su postigli objektivno potvrđen potpuni odgovor ili djelomični odgovor prema neovisnoj,

the aprepitant regimen provided better control than the control regimen with respect to the complete response endpoints.
je bolju kontrolu nego kontrolni režim u pogledu ishoda potpunog odgovora.

The primary efficacy endpoint, Complete Response(CR: no 1o0miting,
Primarni ishod djelotvornosti, potpuni odgovor(CR: izostanak povraćanja,

The disease control rate(complete response plus partial response plus stable disease) was numerically higher
Stopa kontrole bolesti(potpun odgovor plus djelomičan odgovor plus stabilna bolest)

Non- inferiority criteria were met if the lower bound of the 97.5% confidence interval for the difference in Complete Response rates of intravenous palonosetron minus intravenous ondansetron was
Kriteriji neinferiornosti bili su ispunjeni ako je donja granica intervala pouzdanosti od 97,5%, za razliku u stopama potpunog odgovora za intravenski palonosetron minus intravenski ondansetron,

the stratum adjusted Mantel-Haenszel statistical non-inferiority confidence interval for the difference in the primary endpoint, complete response(CR), was[-10.5,
prema Mantel-Haenszelovom statističkom intervalu pouzdanosti za neinferiornost prilagođenom za slojeve za razliku u primarnom ishodu, potpuni odgovor(CR), bio je[-10,

The primary efficacy variable was the proportion of patients with a complete response(CR, defined as no emetic episode
Varijabla primarne djelotvornosti bila je udio bolesnika s potpunim odgovorom(CR(engl. complete response),